FDA User Fee Corrections Act of 2012

Pub. L. 112–193

US Codex doesn’t hold the enacted text of this law — the public-law corpus runs from the 113th Congress (2013) onward. What it changed in the U.S. Code, reconstructed from the credit notes, is listed below.

4 sections of the Code credited to this law, found between Public Law 112-90 and Public Law 112-283.

• 21 U.S.C. § 352 — Misbranded drugs and devices
• 21 U.S.C. § 379j — Authority to assess and use device fees
• 21 U.S.C. § 379j-42 — 379j–42. Authority to assess and use human generic drug fees
• 21 U.S.C. § 379j–42 — Authority to assess and use human generic drug fees